Skip to main content

Table 1 Biochemical and clinical data for study participants, aged 15–34 at onset of diabetes, with or without development of diabetic nephropathy (DN) within 10 years after onset of diabetes

From: Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15–34 years of age: a prospective cohort study

 

No nephropathy (n = 199)

Nephropathy (n = 21)

p value

sST2 (pg/ml)

723 [449–1084]

1012 [777–1493]

0.006

sCD163 (ng/ml)

287 [221–386]

346 [299–450]

0.058

BMI (kg/m2)

25.1 ± 3.5

25.1 ± 4.1

0.911

Age (years)

25.0 ± 5.5

26.7 ± 6.1

0.181

HbA1c (mmol/mol (%))

66.1 ± 15.6 (8.2 ± 1.4)

74.0 ± 17.2 (8.9 ± 1.6)

0.031

Sex (men/women)

118/81

15/6

0.397

Type 1/type 2 diabetes

122/77

9/12

0.160